Intan Baru Prana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Intan Baru Prana Tbk. is more actively traded (799.4K versus 324K). Which is the better fit depends on your goals.
| IBFN | OBAT | |
|---|---|---|
Market Cap | 103.18B | 166.01B |
Volume | 799.4K | 324K |
Lot | 7.99K | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Read more on IBFN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →